Don't Retract Pack

Routine Circumcision: The Opposing View

By Andrew E MacNeily, MD, FRCSC, FAAP
Source: Can Urol Assoc J. 2007 November; 1(4): 395–397

For millennia, routine newborn male circumcision has been endorsed for a variety of purported benefits. Over the ages, claimed advantages have included the formation of a covenant with god, the enhancement of sexual pleasure, the reduction of sexual pleasure, and a cure for bedwetting, syphilis, penile cancer, mental illness and masturbation. In more modern times, some advocates of circumcision have equated the procedure to a form of vaccination. Circumcision is thus depicted as protective against future problems of the foreskin such as phimosis and recurrent balanitis as well as neonatal urinary infection (UTI), cervical carcinoma and HIV/AIDS. Do these potential advantages justify routine circumcision of healthy newborn males on a widespread scale? Should public policy dictate that health care resources be redirected to this procedure when all but 1 province in Canada has delisted newborn circumcision from the schedule of insured services? Let's look at the evidence.

Prevention of urinary tract infection

It is well established from epidemiological studies first carried out by Wiswell and colleagues that the incidence of febrile UTI in otherwise anatomically normal males in the first year of life is lower in circumcised, compared with intact, males. The exact risk reduction varies somewhere between 4-fold and 12-fold depending on the study one chooses to quote. However, the actual incidence of UTI in the first year of life is low. Even a 10-fold reduction in infection rates equates to changing the incidence of UTI from 1 in 100 to 1 in 1000 male babies. It has been calculated that the rate of UTI among infant boys with foreskins must equal or exceed 29% for neonatal circumcision to be cost effective. Conversely, for neonatal circumcision to be cost- neutral, each patient hospitalized for UTI would need to cost $229 564! In 2004, it is estimated that approximately 1.2 million newborn circumcisions were performed in the United States. The estimated direct cost of these procedures was $1.2 billion, a large sum of health care funds that could be directed toward more effective preventative and therapeutic interventions.

Prevention of HIV/AIDS

A complete discussion of the relation of male circumcision and HIV is beyond the scope of this paper. Some studies conducted in Africa have shown that HIV is more common in uncircumcised males, while others have shown the opposite or no difference. Despite the fact that the evidence indicating a protective effect of circumcision is based on observational studies of adult circumcision in a developing country, there is now a ground swell of support for considering the procedure as a viable strategy for preventing sexually acquired infections. A recent Cochrane systematic review found insufficient evidence to support an interventional effect of male circumcision on HIV acquisition in heterosexual men. The authors noted that individual “researcher's personal biases and the dominant circumcision practices of their respective countries” complicated the interpretation of the existing data on the effect of circumcision on HIV transmission rates. Three randomized controlled trials (RCTs) have subsequently been published on heterosexual female-to-male transmission of HIV in high-risk areas of sub-Saharan Africa.,,, All 3 supported adult circumcision as a protective measure. However, these trials were all terminated early, a characteristic that tends to overstate the effect of an intervention. In North America, where HIV rates are much lower, transmission is primarily by homosexual contact and intravenous drug use, making these RCTs inapplicable to this jurisdiction. Further, based on 1998 WHO data of developed countries, the United States has the highest rate of HIV and also the highest rate of infant circumcision.This alone casts doubt on the utility of routine circumcision in preventing HIV infection in developed countries.

Prevention of cervical carcinoma

It has been observed that the prevalence of cervical cancer is low where male circumcision is practised. Historically, this has been attributed to a decreased prevalence of human papilloma virus (HPV) on the circumcised penis. However, a recent meta-analysis on HPV and circumcision concluded that the medical literature does not support the claim that circumcision reduces the risk of genital HPV infection. Even if circumcision conferred a reduction of HPV, does that indicate that routine circumcision should be advocated to reduce the prevalence of the vector for cervical cancer? The use of surgery for disease prevention is an unusual public health intervention. It would seem a more prudent health care policy to offer the recently available HPV vaccine against oncogenic strains of the virus to young females before the onset of sexual activity than to perform surgery on all males in the neonatal period.

Prevention of penile carcinoma

Over the last 75 years, many case series showing that most penile cancers occurred in uncircumcised individuals have been published. Does that indicate that all males should be circumcised to prevent this rare cancer? It is notable that the incidences of penile cancer in Denmark, Finland, Norway and Japan, where less than 1.5% of men are circumcised, are lower than in the United States, where the majority of men are still circumcised.,,,, If circumcision is believed to decrease the risk of developing cancer, why do these noncircumcising countries with similar standards of living and hygiene have lower incidences of penile cancer?
The American Academy of Pediatrics policy notes that 9–10 cases of penile cancer are diagnosed each year per 1 million men, indicating that, although the risk is higher for uncircumcised men, the overall risk is extremely low. Because this disease is rare and occurs later in life, advocating circumcision as a preventive practice is difficult to justify.

Prevention of future foreskin problems

One of the difficulties in assessing the incidence of foreskin problems in the non-circumcised male is that of defining “phimosis.” All newborn males have a physiologic phimosis, with the glans adherent to the inner mucosal surface of the prepuce. Gradual separation of the glans from prepuce takes place spontaneously over many years, often not being complete until puberty. Referrals for circumcision later in childhood because of an asymptomatic non-retractile foreskin, possibly with some ballooning upon voiding, are commonly made in error. Usually, in this setting, anxious parents and referring physicians require education on the care of the normal foreskin and the patient does not require an operation. The Canadian Pediatric Society states that no more than 1% of boys will require post-neonatal circumcision, and Australian reports indicate that normal preputial adhesions are often misdiagnosed as phimosis, leading to unnecessary circumcisions., The rate of true pathological phimosis is less than 1% and this usually responds to a short course of topical steroid ointment.Occasionally, uncircumcised boys experience an episode of balanitis requiring oral antibiotic therapy. The rate of this is estimated at 1%–2% and does not justify prophylactic or therapeutic circumcision.An analogous situation would be to recommend myringotomy and tubes in every child who suffers an episode of otitis media.

Complications of newborn circumcision

Health is not only about disease prevention, but also about well-being and the avoidance of harm. How harmful is routine non-therapeutic circumcision? The overall rate of immediate and long-term complications arising from newborn circumcision is a matter of debate and in truth unknown. The estimated rate of complication worldwide has been reported as lying between the extremes of 0.1% and 35%. Minor complications such as bleeding, infection and prolonged hospitalization are thought to occur in less than 5% of cases. Tragic partial or complete penile amputation, urethral injury and even the rare death have been reported. Meatal stenosis requiring intervention occurs in 5%–10% of males circumcised in the newborn period. This is believed to be secondary to dermatitis of the unprotected glans exposed to wet diapers. Circumcision revision under anesthetic for penile concealment, skin bridges or an unacceptable cosmetic result is probably the most common long-term complication prompting a urological referral: in one survey, fully one-third of pediatric urologists in the United States reported experience as an expert witness in circumcision litigation cases.


Newborn circumcision remains an area of controversy. Social, cultural, aesthetic and religious pressures form the most common reasons for non-therapeutic circumcision. Although penile cancer and UTIs are reduced compared with uncircumcised males, the incidence of such illness is so low that circumcision cannot be justified as prophylaxis. The role of the foreskin in HIV transmission in developed countries is unclear, and safe sexual practice remains the cornerstone of prevention. There remains a lack of knowledge regarding what constitutes the normal foreskin both among parents and among primary care providers. This lack of knowledge results in a burden of costs to our health care system in the form of unnecessary urological referrals, expansion of wait times and circumcisions. Routine circumcision of all infants is not justified from a health or cost-benefit perspective.


This article has been peer reviewed.
Competing interests: None declared.


1. Dalton JD. Male circumcision – see the harm to get a balanced picture. JMGH 2007;4:312-7.
2. Schoen EJ. Circumcision as a lifetime vaccination with many benefits. JMHG 2007;4: 306-11.
3. Wiswell TE, Smith FR, Bass JW. Decreased incidence of urinary tract infections in circumcised male infants. Pediatrics 1985;75:901-3. [PubMed]
4. Chessare JB. Circumcision: is the risk of urinary tract infection really the pivotal issue? Clin Pediatr (Phila) 1992;31:100-4. [PubMed]
5. Van Howe RS. A Cost-utility analysis of neonatal circumcision. Med Decis Making 2004;24:584-601.[PubMed]
6. Hill G. The Case Against Circumcision. JMHG 2007;4:318-23.
7. Siegfried N, Muller M, Volmink J, et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2003; CD003362. [PubMed]
8. Denniston GC. Hill G. Male circumcision in HIV prevention. Lancet 2007;369:1598. [PubMed]
9. Bailey RC, Moses S, Parker C, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet 2007;369:643-56. [PubMed]
10. Gray RH, Kigoze G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007;369:657-66. [PubMed]
11. Auvert B, Taljaard D, Lagarde E, et al. Randomised controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005;2:e298. [PMC free article][PubMed]
12. Van Howe RS. Human papillomavirus and circumcision: A meta-analysis. J Infect 2007;54:490-6.[PubMed]
13. Rambout L, Hopkins L, Hutton B, et al. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ2007;177:469-79. [PMC free article] [PubMed]
14. Frisch M, Friis S, Kruger-Kjaer S, et al. Falling incidence of penis cancer in an uncircumcised population (Denmark 1943-90). BMJ 1995;311:1471. [PMC free article] [PubMed]
15. Iverson T, Tretli S, Johansen A, et al. Squamous cell carcinoma of the penis and of the cervix, vulva and vagina in spouses: is there any relationship? An epidemiological study from Norway, 1960-92. Br J Cancer 1997;76:658-60. [PMC free article] [PubMed]
16. Maiche AG. Epidemiological aspects of cancer of the penis in Finland. Eur J Cancer Prev1992;1:153-8. [PubMed]
17. Muir CS, Nectoux J. Epidemiology of cancer of the testis and penis. Natl Cancer Inst Monogr1979;53:157-64. [PubMed]
18. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30. [PubMed]
19. Hirji H, Charlton R, Sarmah S. Male circumcision: a review of the evidence. JMHG 2005;2:21-30.
20. Cold CJ, Taylor JR. The prepuce. BJU Int 1999;83(suppl 1):34-44. [PubMed]
21. McGregor TB, Pike JG, Leonard MP. Phimosis-A diagnostic dilemma? Can J Urol 2005;12:2598-602. [PubMed]
22. Canadian Paediatric Society. 2007. A:vailable: /circumcision.htm (accessed 2007 Sept 20).
23. Spilsbury K, Semmens JB, Wisniewski ZS, et al. Circumcision for phimosis and other medical indications in Western Australian boys. Med J Aust 2003;178:155-8. [PubMed]
24. Shankar KR, Rickwood AM. The incidence of phimosis in boys. BJU Int 1999;84:101-2. [PubMed]
25. Ashfield JE, Nickel KR, Siemens DR, et al. Treatment of phimosis with topical steroids in 194 children. J Urol 2003;169:1106-8. [PubMed]
26. Escala JM, Rickwood AM. Balanitis. Br J Urol 1989;63:196-7. [PubMed]
27. Christakis DA, Harvey E, Zerr DM, et al. A trade-off analysis of routine newborn circumcision.Pediatrics 2000;105:246-9. [PubMed]
28. Van Howe RS. Incidence of meatal stenosis following neonatal circumcision in a primary care setting. Clin Pediatr (Phila) 2006;45:49-54. [PubMed]
29. Gibson DM. Re: cost analysis of neonatal circumcision in a large health maintenance organization. J Urol 2006;175:2316-7. [PubMed]

No comments:

Post a Comment